ClinicalTrials.gg
Not yet recruitingNCT07820475SERENITYUpdated Nov 3, 2026

SERENITY Study of Chronic Pain Interference in Adults

An observational study in Chronic Low Back Pain, Spinal Cord Injury and Neuropathic Pain, sponsored by University of Minnesota. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of Minnesota · Observational

Updated Nov 3, 2026Start date movedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.

Started
2026
with 1 other
Observational
3 of 15
2 open now
Registered
15th of 15
by date

Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is one of 2 that started in 2026, is one of 3 observational ones, and was the 15th registered.

By phase

15 studies; the count open now beside each. This study's row is marked.

No phase8 · 4 open
Observationalthis study3 · 2 open
Phase 1/22 · 1 open
Phase 21 · 0 open
Phase 31 · 0 open

By the year they started

First in 2015; this study’s year is marked. 2 started in 2026.

Size and results

Median enrollment 38 across the 12 interventional studies, 113 across the 3 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 15 studies in Spinal Cord Injuries by University of Minnesota, or all of them as a file.
02

Study summary

SERENITY is a remote observational study designed to characterize inter-individual differences in chronic pain among adults with chronic low back pain and adults with spinal cord injury-related neuropathic pain.

Participants will complete baseline assessments and intensive longitudinal data collection using ecological momentary assessment surveys, brief cognitive tests, and passive Fitbit data collection. Ecological momentary assessment surveys will be completed 4 times per day for at least 3 weeks and will assess pain interference, pain intensity, stress, affect, sleep, body and mind awareness, agency, medication use, manual therapy frequency, and related factors.

The study will use Bayesian hierarchical modeling, clustering analyses, and causal discovery approaches to identify person-specific and group-level factors associated with pain interference.

Read the detailed description

Chronic pain is heterogeneous, and individuals with similar pain diagnoses may experience different levels of pain interference and may have different factors contributing to pain-related disability. SERENITY is a remote observational study designed to characterize between-subject heterogeneity in adults with chronic low back pain and adults with spinal cord injury-related neuropathic pain.

The study will enroll 200 adults with chronic low back pain and 200 adults with spinal cord injury-related neuropathic pain. Participants will complete baseline demographic, clinical, pain, emotional functioning, physical functioning, and quality-of-life assessments. Participants will also complete ecological momentary assessment surveys 4 times per day for at least 3 weeks. These surveys will assess pain intensity, pain interference with function, positive and negative affect, stress, sleep, body and mind awareness, agency or perceived control over pain and life, medication dosage, manual therapy frequency, and brief cognitive test performance.

Fitbit data will be collected passively during the study period to measure sleep, physical activity, heart rate, heart rate variability, daily readiness, and stress management. The study will use intensive longitudinal data from ecological momentary assessment surveys and Fitbit measures to develop Bayesian hierarchical models, pain-profile clusters, and personal causal models.

The primary objective is to identify SERENITY measures associated with or causally related to pain interference within each pain group. The study will also examine heterogeneity in pain profiles and explore person-specific causal relationships between pain interference and measures of pain severity, stress, cognition, body and mind awareness, affect, and agency.

03

Conditions studied

  • Chronic Low Back Pain
  • Spinal Cord Injury
  • Neuropathic Pain
  • Chronic Pain
  • Pain Interference

Keywords

  • EMA
  • SERENITY
  • Chronic pain
  • Chronic low back pain
  • Fitbit
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with chronic low back pain and adults with spinal cord injury-related neuropathic pain will be recruited nationwide for this remote observational study. Participants will be 18 years or older, medically stable, fluent in English, and have pain severity of at least 4 out of 10 over the past week. Participants will complete baseline assessments and intensive longitudinal data collection using ecological momentary assessment surveys, brief cognitive tests, and passive Fitbit data collection.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Chronic low back pain for more than 3 months, or complete or incomplete spinal cord injury for more than 1 year with spinal cord injury-related neuropathic pain
  • Medically stable
  • Pain severity of at least 4 out of 10 on the numeric pain rating scale over the past week
  • Fluent in English
  • Access to the internet and a computer, iPad, or smartphone; study equipment may be provided if needed
  • Currently on stable pain medication or manual therapy appointments as part of clinical care

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment or communicative disability preventing the participant from following directions
  • Major medical complications
  • Pregnancy
  • Current active treatments that could potentially influence SERENITY outcomes, such as cognitive behavioral therapy or Qigong
  • Children
  • Prisoners
  • Adults lacking capacity to consent or adults with diminished or fluctuating capacity to consent
  • Non-English speakers
  • Individuals unable to read
  • Employees of the researcher
  • Students of the researcher
  • Active members of the military or DoD personnel
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adults With Chronic Low Back Pain

    Adults with chronic low back pain for more than 3 months and pain severity of at least 4 out of 10 over the past week. Participants will complete baseline questionnaires, ecological momentary assessment surveys, brief cognitive tests, and passive Fitbit data collection.

  • Adults With SCI-Related Neuropathic Pain

    Adults with complete or incomplete spinal cord injury of more than 1 year, medically stable, with spinal cord injury-related neuropathic pain and pain severity of at least 4 out of 10 over the past week. Participants will complete baseline questionnaires, ecological momentary assessment surveys, brief cognitive tests, and passive Fitbit data collection.

06

What researchers measure

Primary outcomes

  1. Pain Interference With Function

    Pain interference with function will be assessed using a single ecological momentary assessment item: "How much is your low back pain/neuropathic pain affecting your daily life function?" Response options range from 0 to 4, with higher scores indicating worse pain interference with function. This is not a standardized scale and is administered via ecological momentary assessment to support causal discovery pathways. Unit: points

    Time frame: Four times daily for at least 3 weeks

Secondary outcomes

  1. Pain, Enjoyment of Life and General Activity Scale Score

    Pain severity and impact will be assessed using the Pain, Enjoyment of Life and General Activity scale. This 3-item scale has a minimum score of 0 and maximum score of 30, with higher scores indicating worse pain severity and impact. Unit: points

    Time frame: Baseline

  2. Brief Pain Inventory Short Form Pain Severity Composite Score

    Pain severity will be assessed using the Brief Pain Inventory Short Form 7-day recall. The pain severity composite includes 4 items, with scores ranging from 0 to 10. Higher scores indicate worse pain severity. Unit: points

    Time frame: Baseline

  3. Brief Pain Inventory Short Form Pain Interference Composite Score

    Pain interference will be assessed using the Brief Pain Inventory Short Form 7-day recall. The pain interference composite includes 7 items, with scores ranging from 0 to 10. Higher scores indicate worse pain interference. Unit: Points

    Time frame: Baseline

  4. Spinal Cord Injury Functional Index/Assistive Technology Score

    Physical functioning among participants with spinal cord injury will be assessed using the Spinal Cord Injury Functional Index/Assistive Technology measure. This 32-item measure has a minimum score of 0 and maximum score of 128, with higher scores indicating better physical functioning. Unit: Points

    Time frame: Baseline

  5. Roland-Morris Low Back Pain and Disability Questionnaire Score

    Low back pain-related disability among participants with chronic low back pain will be assessed using the Roland-Morris Low Back Pain and Disability Questionnaire. This 24-item measure has a minimum score of 0 and maximum score of 24, with higher scores indicating worse disability. Unit: Points

    Time frame: Baseline

  6. Patient Health Questionnaire-4 Score

    Depression and anxiety symptoms will be assessed using the Patient Health Questionnaire-4. This 4-item measure has a minimum score of 0 and maximum score of 12, with higher scores indicating worse depression and anxiety symptoms. Unit: Points

    Time frame: Baseline

  7. World Health Organization Quality of Life 2-Item Score

    Quality of life and health satisfaction will be assessed using the World Health Organization Quality of Life 2-item measure. Each item is scored on a 5-point Likert scale. Total scores range from 2 to 10, with higher scores indicating better quality of life and health satisfaction. Unit: Points

    Time frame: Baseline

  8. Cognitive and Affective Mindfulness Scale-Revised Score

    Mindful qualities will be assessed using the Cognitive and Affective Mindfulness Scale-Revised. This 12-item measure is scored from 1 to 4 per item. Total scores range from 1 to 48, with higher scores indicating better mindfulness-related qualities. Unit: Points

    Time frame: Baseline

  9. Pain Resilience Scale Score

    Pain resilience will be assessed using the Pain Resilience Scale. This 14-item measure uses a 5-point Likert scale scored from 0 to 4 per item. Total scores range from 0 to 56, with higher scores indicating better positive adaptation to pain. Unit: Points

    Time frame: Baseline

  10. Positive and Negative Affect Schedule Short Form - Positive Affectivity Score

    Positive affectivity will be assessed using the Positive and Negative Affect Schedule Short Form. Items are scored from 1 to 5. Total scores range from 5 to 25, with higher scores indicating better positive affectivity. Unit: Points

    Time frame: Four times daily for at least 3 weeks

  11. Positive and Negative Affect Schedule Short Form - Negative Affectivity Score

    Negative affectivity will be assessed using the Positive and Negative Affect Schedule Short Form. Items are scored from 1 to 5. Total scores range from 5 to 25, with higher scores indicating worse negative affectivity. Unit: Points

    Time frame: Four times daily for at least 3 weeks

  12. EMA Relaxation Score

    Relaxation will be assessed using a single ecological momentary assessment item scored from 0 to 4, with higher scores indicating better relaxation. Unit: points

    Time frame: Four times daily for at least 3 weeks

  13. EMA Energy Score

    Energy will be assessed using a single ecological momentary assessment item scored from 0 to 4, with higher scores indicating better energy. Unit: points

    Time frame: Four times daily for at least 3 weeks

  14. EMA Control Score

    Perceived control will be assessed using a single ecological momentary assessment item scored from 0 to 4, with higher scores indicating better perceived control. Unit: points

    Time frame: Four times daily for at least 3 weeks

  15. EMA Sleep Difficulty Score

    Sleep difficulty will be assessed using single ecological momentary assessment items related to trouble falling asleep, trouble staying asleep, and waking up too early. Each item will be scored separately from 0 to 4, with higher scores indicating worse sleep difficulty. Unit: points

    Time frame: Four times daily for at least 3 weeks

  16. EMA Fear of Movement Score

    Fear of movement because of pain will be assessed using a single ecological momentary assessment item scored from 0 to 4, with higher scores indicating worse fear of movement. Unit: points

    Time frame: Four times daily for at least 3 weeks

  17. EMA Pain Intensity Score

    Pain intensity will be assessed using a single ecological momentary assessment item measuring pain intensity at the time of assessment. Scores range from 0 to 10, with higher scores indicating worse pain intensity. Unit: points

    Time frame: Four times daily for at least 3 weeks

  18. Time to Completion for EMA Number Sequencing Task

    Attention will be assessed using a smartphone-based number sequencing task. Performance will be reported as time to completion. Unit: Seconds

    Time frame: Four times daily for at least 3 weeks

  19. Time to Completion for EMA Number-Letter Sequencing Task

    Set-shifting will be assessed using a smartphone-based number-letter sequencing task. Performance will be reported as time to completion. Unit: Seconds

    Time frame: Four times daily for at least 3 weeks

  20. Percent Correct for EMA Spatial Working Memory Task

    Spatial working memory will be assessed using a smartphone-based spatial working memory task. Performance will be reported as percent correct. Unit: percent correct

    Time frame: Four times daily for at least 3 weeks

  21. Fitbit-Derived Sleep Duration

    Sleep duration will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: hours

    Time frame: Throughout the study assessment period, at least 3 weeks

  22. Fitbit-Derived Physical Activity

    Physical activity will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: Steps

    Time frame: Throughout the study assessment period, at least 3 weeks

  23. Fitbit-Derived Heart Rate

    Heart rate will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: beats per minute

    Time frame: Throughout the study assessment period, at least 3 weeks

  24. Fitbit-Derived Heart Rate Variability

    Heart rate variability will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: milliseconds

    Time frame: Throughout the study assessment period, at least 3 weeks

  25. Fitbit-Derived Daily Readiness Score

    Daily readiness will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: points

    Time frame: Throughout the study assessment period, at least 3 weeks

  26. Fitbit-Derived Stress Management Score

    Stress management will be measured passively using Fitbit Charge 6 during the study assessment period. Unit: points

    Time frame: Throughout the study assessment period, at least 3 weeks

07

Study locations

1 site
08

Updates

3 registry updates since Sep 25, 2026
Start date
Oct 1, 2026→Nov 21, 2026
moved 2 times, Oct 6, 2026 – Nov 3, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • University of Minnesota · Minneapolis, United StatesContact •••2500→none listed
Oct 13, 2026
Show all 3 updates
  1. Nov 3, 2026
    Start date Nov 1, 2026→Nov 21, 2026
    + 1 other change: verification date
  2. Oct 13, 2026
    Site contacts Changed at 1 site. See the sites
    Show the site
    • University of Minnesota · Minneapolis, United StatesContact •••2500→none listed
  3. Oct 6, 2026
    Start date Oct 1, 2026→Nov 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07820475
Responsible party
Sponsor
First posted
Sep 15, 2026
Start date
Nov 21, 2026 (estimated)
Primary completion
Sep 30, 2031 (estimated)
Completion
Sep 30, 2031 (estimated)
Last update
Nov 3, 2026

Study contacts

Ann Van de Winckel, PhD, MSPT
Contact
avandewi@umn.edu
6124062500
Ann Van de Winckel, PhD, MSPT
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion